Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2013)
The development and validation of a decisionanalytic model representing the full disease course of acute myeloid leukemia
R. Pataky, R. Gulati, Ruth Etzioni, P. Black, K. Chi, A. Coldman, T. Pickles, S. Tyldesley, S. Peacock (2014)
Is prostate cancer screening cost‐effective? A microsimulation model of prostate‐specific antigen‐based screening for British Columbia, CanadaInternational Journal of Cancer, 135
Zauber AG, Lansdorp-Vogelaar I, Knudsen AB
Evaluating test strategies for colorectal cancer screening: A decision analysis for the U
H. Brachinger, P. Monney (2018)
Decision analysis.The New England journal of medicine, 317 6
K. Cronin, J. Legler, Ruth Etzioni (1998)
Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.Statistics in medicine, 17 21
guideline update from the American Cancer Society
Gulati R, Gore JL, Etzioni R
Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: Model estimates of potential benefits and harms
Eddy DM, Hollingworth W, Caro JJ
Model transparency and validation: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
K. Oeffinger, Elizabeth Fontham, Ruth Etzioni, Abbe Herzig, J. Michaelson, Y. Shih, L. Walter, T. Church, C. Flowers, S. LaMonte, Andrew Wolf, C. DeSantis, J. Lortet-Tieulent, Kimberly Andrews, Deana Manassaram-Baptiste, D. Saslow, Robert Smith, O. Brawley, R. Wender (2015)
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.JAMA, 314 15
David Eddy, W. Hollingworth, J. Caro, J. Tsevat, Kathryn McDonald, John Wong (2012)
Model Transparency and ValidationMedical Decision Making, 32
T. Imperiale, E. Glowinski, C. Lin-Cooper, G. Larkin, J. Rogge, D. Ransohoff, J. Saurin (2008)
Five-Year risk of colorectal neoplasia after negative screening colonoscopyActa Endoscopica, 39
D. Fryback, N. Stout, M. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, P. Remington (2006)
The Wisconsin Breast Cancer Epidemiology Simulation Model.Journal of the National Cancer Institute. Monographs, 36
National Cancer Institute
About the SEER program
National Cancer Institute
SEER-Medicare: Brief description of the SEER-Medicare database
R. Meza, K. Haaf, C. Kong, A. Erdogan, W. Black, M. Tammemagi, Sung-Eun Choi, Jihyoun Jeon, Summer Han, Vidit Munshi, J. Rosmalen, P. Pinsky, P. McMahon, H. Koning, E. Feuer, W. Hazelton, S. Plevritis (2014)
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsCancer, 120
Ruth Etzioni, R. Gulati (2013)
Response: Reading between the lines of cancer screening trials: using modeling to understand the evidence.Medical care, 51 4
H. Brenner, J. Chang-Claude, C. Seiler, T. Stürmer, M. Hoffmeister (2005)
Does a negative screening colonoscopy ever need to be repeated?Gut, 55
L. Clarke, S. Plevritis, R. Boer, K. Cronin, E. Feuer (2006)
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.Journal of the National Cancer Institute. Monographs, 36
A. Zauber, I. Lansdorp-Vogelaar, Amy Knudsen, J. Wilschut, M. Ballegooijen, K. Kuntz (2008)
Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 149
M. Spielauer (2009)
WHAT IS DYNAMIC SOCIAL SCIENCE MICROSIMULATION ?
American College of Physicians
National Cancer Database
R. Gulati, J. Gore, Ruth Etzioni (2013)
Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening StrategiesAnnals of Internal Medicine, 158
American College of Physicians: National Cancer Database
Pataky R, Gulati R, Etzioni R
Is prostate cancer screening cost-effective
(2020)
Cancer Intervention and Surveillance Modeling NetworkDefinitions
Qiushi Chen, T. Ayer, L. Nastoupil, Miray Seward, Hongzhen Zhang, R. Sinha, C. Flowers (2012)
Initial management strategies for follicular lymphoma.International journal of hematologic oncology, 1 1
Briggs AH, Weinstein MC, Fenwick EA
Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
National Cancer Institute
Breast Cancer Risk Assessment Tool
(2015)
Breast cancer screening for women at average risk: 2015 guideline update from the
Clarke LD, Plevritis SK, Boer R
A comparative review of CISNET breast models used to analyze U
James Thompson (2004)
Simulation-based estimation of stochastic process parameters in tumor growth.Comptes rendus biologies, 327 3
(2012)
Comparative analysis of 5 lung
C. Rutter, J. Savarino (2010)
An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and ApplicationCancer Epidemiology, Biomarkers & Prevention, 19
Deirdre Hennessy, W. Flanagan, P. Tanuseputro, C. Bennett, M. Tuna, J. Kopec, M. Wolfson, D. Manuel (2015)
The Population Health Model (POHEM): an overview of rationale, methods and applicationsPopulation Health Metrics, 13
National Cancer Institute: SEER-Medicare: Brief description of the SEER-Medicare database
Andrew Briggs, Dphil, Milton Weinstein, Elisabeth Fenwick, J. Karnon, M. Sculpher, A. Paltiel
Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern
(1987)
Kassirer JP: Decision analysis
Mandelblatt JS, Cronin KA, Bailey S
Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms
Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening
(2014)
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia
J. Caro, A. Briggs, U. Siebert, K. Kuntz (2012)
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 15 6
C. Kong, P. McMahon, G. Gazelle (2009)
Calibration of disease simulation model using an engineering approach.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12 4
Purpose: Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the simulation of downstream events on the basis of predefined states and transition probabilities between those states over time. In this article, we describe the history of the role of microsimulation in medicine and its potential applications in oncology as useful tools for population risk stratification and treatment strategy design for precision medicine. Methods: We conducted a comprehensive and methodical search of the literature using electronic databases-Medline, Embase, and Cochrane-for works published between 1985 and 2016. A medical subject heading search strategy was constructed for Medline searches by using a combination of relevant search terms, such as "microsimulation model medicine," "multistate modeling cancer," and "oncology." Results: Microsimulation modeling is particularly useful for the study of optimal intervention strategies when randomized control trials may not be feasible, ethical, or practical. Microsimulation models can retain memory of prior behaviors and states. As such, it allows an explicit representation and understanding of how various processes propagate over time and affect the final outcomes for an individual or in a population. Conclusion: A well-calibrated microsimulation model can be used to predict the outcome of the event of interest for a new individual or subpopulations, assess the effectiveness and cost effectiveness of alternative interventions, and project the future disease burden of oncologic diseases. In the growing field of oncology research, a microsimulation model can serve as a valuable tool among the various facets of methodology available.
JCO Clinical Cancer Informatics – Wolters Kluwer Health
Published: Mar 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.